Results 111 to 120 of about 436,511 (214)

Designing of a multiepitope-based chimeric vaccine against dengue virus serotype 3 (DENV-3) through next generation reverse vaccinology approaches

Informatics in Medicine Unlocked
The dengue virus (DENV) causes dengue infection and has become a significant global public health concern. The successful application of immunotherapies in treating dengue infection has paved the way for developing various treatment strategies.
Md Habib Ullah Masum, Jannatul Ferdous, Syed Lokman, Amam Zonaed Siddiki   +3 more
doaj   +1 more source

The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection

, 2016
[[abstract]]Dengue has a major impact on global public health, and the use of dengue vaccine is very limited. In this study, we evaluated the immunogenicity and protective efficacy of a dengue vaccine made from a recombinant measles virus (MV) that ...
Hu, HM;Chen, HW;Hsiao, YJ;Wu, SH;Chung, HH;Hsieh, CH;Chong, P;Leng, CH;Pan, CH
core   +1 more source

Hanta Virus Infection During Dengue Virus Infection Outbreak in Indonesia [PDF]

, 2009
Aim: to investigate which recent infection could have caused the present dengue-like symptoms, in adult patients clinically fulfilling the WHO criteria for dengue, in which serologically were not confirmed for dengue virus infections.
Hadisaputro, Suharyo, Djokomoeljanto, Robert J., Dolmans, Wil M.V., Groen, Jan, Osterhaus , Ab D.M.E, Suharti, Catharina, Meer, Jos W.M. van der, Gorp, Eric C.M. van   +7 more
core   +1 more source

[Dengue treatments and vaccines].

Medecine sciences : M/S
La dengue est une maladie virale transmise par les moustiques du genre Aedes, dont l’incidence et l’aire de répartition sont en constante augmentation depuis les dernières décennies. Causant des fièvres hémorragiques dans les cas graves, elle touche principalement les zones tropicales et subtropicales du globe, et menace de s’étendre à de nouvelles ...
Brézillon-Dubus, Lazare, Dupuis, Benjamin, Failloux, Anna-Bella   +2 more
openaire   +2 more sources

Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico´s Universal Vaccination Program

Salud Pública de México, 2016
Dengue is a major global public health problem affecting Latin America and Mexico Prevention and control measures, focusing on epidemiological surveillance and vector control, have been partially effective and costly, thus, the development of a vaccine ...
Mauricio Hernández-Ávila, José Ignacio Santos-Preciado   +1 more
doaj  

Prospective Dengue Cohort Studies.

, 2013
Prospective Dengue Cohort Studies.
WHO-VMI Dengue Vaccine Modeling Group (614252)
core   +1 more source

Proceedings of the inaugural symposium on dengue human challenge studies "Challenging the norm: Accelerating dengue countermeasures through human studies".

PLoS Neglected Tropical Diseases
On 12th June 2025, Duke-NUS Medical School, supported by the Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC), hosted a one-day symposium in Singapore titled "Challenging the norm: Accelerating dengue countermeasures through human challenge
Shirin Kalimuddin, Adam T Waickman, Panisadee Avirutnan, Mohammad Shafiul Alam, Christopher Chiu, Barnaby E Young, Christopher W Woods, Petra C Fay, Sheila K Pakir, Jo-Anne Manski-Nankervis, Claus Bolte, Andrew Pengilley, Marco Cavaleri, John C W Lim, Stephen J Thomas, Albert I Ko, Eng Eong Ooi   +16 more
doaj   +1 more source

Biological control of dengue and Wolbachia-based strategies. 2nd ed.

, 2014
This book chapter describes a number of biological control methods that currently exist, or are under development, which target the dengue vector Aedes aegypti.
Vasudevan, S, Frentiu, Scott L., F. D. Frentiu, Frentiu, F, Walker, T, Farrar, J, T. Walker, Walker, Thomas, O'Neil, Scott L., S. L. O'Neill, O'Neill, Scott L., Ooi, E, O'Neill, S, Gubler, D, Frentiu, Francesca D.   +14 more
core   +1 more source

Barriers to dengue vaccine uptake in international travelers: a mixed-methods study

Expert Review of Vaccines
Background Dengue poses a growing threat to international travelers, yet vaccine uptake remains limited due to inconsistent guidelines and psychological barriers. This study provides barriers and determinants of hesitancy, which may guide strategies once
Rachata Charoenwisedsil, Saranath Lawpoolsri, Pinyo Rattanaumpawan, Narisa Ruenroengbun, Gerard T. Flaherty, Daniel M. Parker, Thundon Ngamprasertchai   +6 more
doaj   +1 more source

Dengue and Dengue Vaccines [PDF]

The Journal of Infectious Diseases, 2005
openaire   +1 more source